Last updated on November 2017


Brief description of study


Detailed Study Description

A 52 week double-blind, placedbo controlled study to evaluate the effect of roflumilast on the exacerbation rate in patients with COPD.

Clinical Study Identifier: TX81215

Contact Investigators or Research Sites near you

Start Over

Baylor Scott & White Research ...

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »